Canada Markets closed

Algernon Pharmaceuticals Inc. (AGN.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.2900+0.0150 (+5.45%)
At close: 3:59PM EST
Currency in CAD

Valuation Measures

Market Cap (intraday) 531.92M
Enterprise Value 328.89M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.40
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-4.80

Trading Information

Stock Price History

Beta (5Y Monthly) -0.21
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.5800
52 Week Low 30.0450
50-Day Moving Average 30.2714
200-Day Moving Average 30.2977

Share Statistics

Avg Vol (3 month) 3431.01k
Avg Vol (10 day) 3431.74k
Shares Outstanding 5110.06M
Float 126.39M
% Held by Insiders 17.05%
% Held by Institutions 17.38%
Shares Short (Oct. 14, 2020) 4204.37k
Short Ratio (Oct. 14, 2020) 40.55
Short % of Float (Oct. 14, 2020) 4N/A
Short % of Shares Outstanding (Oct. 14, 2020) 40.19%
Shares Short (prior month Sep. 14, 2020) 4349.43k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Oct. 16, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug. 30, 2019
Most Recent Quarter (mrq)May 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-37.66%
Return on Equity (ttm)-63.76%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -6.02M
Net Income Avi to Common (ttm)-5.98M
Diluted EPS (ttm)-0.0850
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.39M
Total Cash Per Share (mrq)0.06
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.44
Book Value Per Share (mrq)0.12

Cash Flow Statement

Operating Cash Flow (ttm)-3.67M
Levered Free Cash Flow (ttm)-1.56M